GeneTex

  • Country / Location Selection

United States (US)

NDUFB9 antibody

Anti-NDUFB9 antibody used in IHC (Paraffin sections) (IHC-P). GTX85007
Anti-NDUFB9 antibody used in IHC (Paraffin sections) (IHC-P). GTX85007
Anti-NDUFB9 antibody used in Western Blot (WB). GTX85007

Cat. No. GTX85007

Host

 Rabbit

Clonality

 Polyclonal

Isotype

 IgG

Application

 WB, IHC-P, ELISA

Reactivity

 Human, Mouse, Rat
Package
100 μg ($419)
See all NDUFB9 products

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
WB 1 - 2 μg/mL
IHC-P 5 μg/mL
ELISA Assay dependent
Not tested in other applications.

Calculated MW

22 kDa. ( Note )

Positive Control

Human Liver Tissue Lysate

PROPERTIES

Form

Liquid

Buffer

PBS

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

1 mg/ml (Please refer to the vial label for the specific concentration.)

Antigen Species

Human

Immunogen

LYRM3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human LYRM3.The immunogen is located within the last 50 amino acids of LYRM3.

Purification

Purified by antigen-affinity chromatography

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

NADH:ubiquinone oxidoreductase subunit B9 , B22 , CI-B22 , LYRM3 , MC1DN24 , UQOR22

Cellular Localization

Mitochondrion inner membrane

Background

NDUFB9, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.

Database

Research Area

DATA IMAGES

Anti-NDUFB9 antibody used in IHC (Paraffin sections) (IHC-P). GTX85007

GTX85007 IHC-P Image

IHC-P analysis of rat liver tissue using GTX85007 NDUFB9 antibody.
Working concentration : 20 μg/ml

Anti-NDUFB9 antibody used in IHC (Paraffin sections) (IHC-P). GTX85007

GTX85007 IHC-P Image

IHC-P analysis of rat liver tissue using GTX85007 NDUFB9 antibody.
Working concentration : 5 μg/ml

Anti-NDUFB9 antibody used in Western Blot (WB). GTX85007

GTX85007 WB Image

WB analysis of human liver tissue lysate using GTX85007 NDUFB9 antibody.
Working concentration : (A) 1 and (B) 2 μg/ml

REFERENCE

There are currently no references for NDUFB9 antibody (GTX85007). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for NDUFB9 antibody (GTX85007). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 419